Production (Stage)
Citius Oncology, Inc.
CTOR
$1.39
-$0.08-5.44%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.00% | 0.00% | -- | -- | -- |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 6.66% | 73.92% | -- | -- | -- |
Prepaid Expenses | 0.00% | 0.00% | -73.02% | 12.35% | 15.15% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 5.61% | 55.73% | 9.61% | 12.35% | 15.15% |
|
|||||
Total Current Assets | 5.61% | 55.73% | 9.61% | 12.35% | 15.15% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 83.50% | 0.00% | 0.00% |
Total Assets | 1.06% | 7.25% | 68.71% | 2.25% | 2.46% |
|
|||||
Total Accounts Payable | 30.67% | 58.28% | -- | -- | 145.80% |
Total Accrued Expenses | 49.74% | 1,449.75% | -98.12% | 15.77% | 15.35% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -- | -- | -- |
Total Other Current Liabilities | 0.00% | 0.00% | -- | -- | -- |
Total Current Liabilities | 14.61% | 32.72% | 4.17% | 13.66% | 16.47% |
|
|||||
Total Current Liabilities | 14.61% | 32.72% | 4.17% | 13.66% | 16.47% |
Long-Term Debt | 0.00% | 0.00% | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 13.27% | 15.29% | 9.09% | 10.00% | 11.11% |
Total Liabilities | 13.43% | 28.68% | 15.93% | 13.48% | 16.20% |
|
|||||
Common Stock & APIC | 2.39% | 2.12% | 72.58% | 4.12% | 4.29% |
Retained Earnings | -16.84% | -16.95% | -20.99% | -17.23% | -21.16% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -13.68% | -10.51% | 170.92% | -14.19% | -12.67% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -13.68% | -10.51% | 170.92% | -14.19% | -12.67% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -13.68% | -10.51% | 170.92% | -14.19% | -12.67% |
|